These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 23055341

  • 1. Drug-targeting in combined cancer chemotherapy: tumor growth inhibition in mice by association of paclitaxel and etoposide with a cholesterol-rich nanoemulsion.
    Kretzer IF, Maria DA, Maranhão RC.
    Cell Oncol (Dordr); 2012 Dec; 35(6):451-60. PubMed ID: 23055341
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Association of daunorubicin to a lipid nanoemulsion that binds to low-density lipoprotein receptors enhances the antitumour action and decreases the toxicity of the drug in melanoma-bearing mice.
    Contente TC, Kretzer IF, Filippin-Monteiro FB, Maria DA, Maranhão RC.
    J Pharm Pharmacol; 2014 Dec; 66(12):1698-709. PubMed ID: 25131262
    [Abstract] [Full Text] [Related]

  • 4. Evaluation in melanoma-bearing mice of an etoposide derivative associated to a cholesterol-rich nano-emulsion.
    Lo Prete AC, Maria DA, Rodrigues DG, Valduga CJ, Ibañez OC, Maranhão RC.
    J Pharm Pharmacol; 2006 Jun; 58(6):801-8. PubMed ID: 16734981
    [Abstract] [Full Text] [Related]

  • 5. Regression of Atherosclerotic Plaques of Cholesterol-Fed Rabbits by Combined Chemotherapy With Paclitaxel and Methotrexate Carried in Lipid Core Nanoparticles.
    Gomes FLT, Maranhão RC, Tavares ER, Carvalho PO, Higuchi ML, Mattos FR, Pitta FG, Hatab SA, Kalil-Filho R, Serrano CV.
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):561-569. PubMed ID: 29779420
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Improvement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion: in vitro and in vivo studies.
    Rodrigues DG, Maria DA, Fernandes DC, Valduga CJ, Couto RD, Ibañez OC, Maranhão RC.
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):565-76. PubMed ID: 15726368
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of patients with aortic atherosclerotic disease with paclitaxel-associated lipid nanoparticles.
    Shiozaki AA, Senra T, Morikawa AT, Deus DF, Paladino-Filho AT, Pinto IM, Maranhão RC.
    Clinics (Sao Paulo); 2016 Aug; 71(8):435-9. PubMed ID: 27626473
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of combined chemotherapy with etoposide and methotrexate, both associated to lipid nanoemulsions for atherosclerosis treatment in cholesterol-fed rabbits.
    Leite AC, Solano TV, Tavares ER, Maranhão RC.
    Cardiovasc Drugs Ther; 2015 Feb; 29(1):15-22. PubMed ID: 25672520
    [Abstract] [Full Text] [Related]

  • 12. Synergy of the combination of nedaplatin with etoposide in murine and human lung carcinoma.
    Uchida N, Kasai H, Takeda Y, Maekawa R, Sugita K, Yoshioka T.
    Anticancer Res; 1998 Feb; 18(1A):247-52. PubMed ID: 9568085
    [Abstract] [Full Text] [Related]

  • 13. Sterically stabilized etoposide liposomes: evaluation of antimetastatic activity and its potentiation by combination with sterically stabilized pentoxifylline liposomes in mice.
    Sant VP, Nagarsenker MS, Rao SG, Gude RP.
    Cancer Biother Radiopharm; 2003 Oct; 18(5):811-7. PubMed ID: 14629829
    [Abstract] [Full Text] [Related]

  • 14. Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit.
    Maranhão RC, Tavares ER, Padoveze AF, Valduga CJ, Rodrigues DG, Pereira MD.
    Atherosclerosis; 2008 Apr; 197(2):959-66. PubMed ID: 18289548
    [Abstract] [Full Text] [Related]

  • 15. Novel formulation of a methotrexate derivative with a lipid nanoemulsion.
    Moura JA, Valduga CJ, Tavares ER, Kretzer IF, Maria DA, Maranhão RC.
    Int J Nanomedicine; 2011 Apr; 6():2285-95. PubMed ID: 22072866
    [Abstract] [Full Text] [Related]

  • 16. Folate Modified Long Circulating Nano-Emulsion as a Promising Approach for Improving the Efficiency of Chemotherapy Drugs in Cancer Treatment.
    Song B, Wu S, Li W, Chen D, Hu H.
    Pharm Res; 2020 Nov 13; 37(12):242. PubMed ID: 33188481
    [Abstract] [Full Text] [Related]

  • 17. Reduction of atherosclerotic lesions in rabbits treated with etoposide associated with cholesterol-rich nanoemulsions.
    Tavares ER, Freitas FR, Diament J, Maranhão RC.
    Int J Nanomedicine; 2011 Nov 13; 6():2297-304. PubMed ID: 22072867
    [Abstract] [Full Text] [Related]

  • 18. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
    Zou L, Liu X, Li J, Li W, Zhang L, Fu C, Zhang J, Gu Z.
    Theranostics; 2021 Nov 13; 11(9):4171-4186. PubMed ID: 33754055
    [Abstract] [Full Text] [Related]

  • 19. LDL mediated delivery of Paclitaxel and MRI imaging probes for personalized medicine applications.
    Rakhshan S, Alberti D, Stefania R, Bitonto V, Geninatti Crich S.
    J Nanobiotechnology; 2021 Jul 13; 19(1):208. PubMed ID: 34256774
    [Abstract] [Full Text] [Related]

  • 20. Polymer-lipid hybrid nanoparticles-based paclitaxel and etoposide combinations for the synergistic anticancer efficacy in osteosarcoma.
    Duan R, Li C, Wang F, Yangi JC.
    Colloids Surf B Biointerfaces; 2017 Nov 01; 159():880-887. PubMed ID: 28892872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.